Search results
Results from the WOW.Com Content Network
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.
23andMe CEO Anne Wojcicki co-founded the company in 2006 with biologist Linda Avey and Paul Cusenza, who previously worked at the now-defunct Perlegen Sciences, which was a biotech startup that ...
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
In 1962, she and her husband, Miguel Terekhov, founded the first fully accredited university dance program in the United States, the School of Dance at the University of Oklahoma. [1] A member of the Shawnee Tribe, she also had French ancestry, the great-great-great-granddaughter of Maj. Jean Pierre Chouteau.
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
Elizabeth Holmes has cast a shadow over women-led startups, especially those in the health sector. But it had "no" impact on consumer trust in 23andMe (ME), CEO Anne Wojcicki tells Yahoo Finance ...
Edward Lewis Gaylord (May 28, 1919 – April 27, 2003) was an American billionaire businessman, media mogul and philanthropist. He was the founder of the Gaylord Entertainment Company that included The Oklahoman newspaper, Oklahoma Publishing Co., Gaylord Hotels, the Nashville Network TV Channel (later renamed SpikeTV, Spike, and Paramount Network after being sold off); the Grand Ole Opry, and ...
Shares of 23andMe rose in their trading debut on the Nasdaq as the consumer genetic testing company became one of the latest companies to go public via SPAC deal. 23andMe shares rise 21% on first ...